Education
About Us
Working with TipRanks
Follow Us
Uni-Bio Science Group Ltd. (HK:0690)
:0690
0690 Stock Chart & Stats
HK$0.13
>-HK$0.01(-3.17%)
At close: 4:00 PM EST
HK$0.13
>-HK$0.01(-3.17%)
Day’s Range― - ―
52-Week RangeHK$0.05 - HK$0.17
Previous CloseN/A
Volume1.74M
Average Volume (3M)6.01M
Market Cap
HK$679.11M
Enterprise ValueHK$612.23M
Total Cash (Recent Filing)HK$170.51M
Total Debt (Recent Filing)HK$108.00M
Price to Earnings (P/E)7.5
Beta-0.23
Next Earnings
Mar 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.29%
Share Statistics
EPS (TTM)0.01
Shares Outstanding5,971,228,000
10 Day Avg. Volume4,607,960
30 Day Avg. Volume6,013,203
Financial Highlights & Ratios
PEG Ratio0.21
Price to Book (P/B)1.13
Price to Sales (P/S)0.67
P/FCF Ratio12.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Uni-Bio Science Group Ltd. News
0690 FAQ
What was Uni-Bio Science Group Ltd.’s price range in the past 12 months?
Uni-Bio Science Group Ltd. lowest stock price was HK$0.05 and its highest was HK$0.17 in the past 12 months.
What is Uni-Bio Science Group Ltd.’s market cap?
Uni-Bio Science Group Ltd.’s market cap is HK$679.11M.
When is Uni-Bio Science Group Ltd.’s upcoming earnings report date?
Uni-Bio Science Group Ltd.’s upcoming earnings report date is Mar 30, 2026 which is in 105 days.
How were Uni-Bio Science Group Ltd.’s earnings last quarter?
Uni-Bio Science Group Ltd. released its earnings results on Aug 28, 2025. The company reported HK$0.013 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.013.
Is Uni-Bio Science Group Ltd. overvalued?
According to Wall Street analysts Uni-Bio Science Group Ltd.’s price is currently Overvalued.
Does Uni-Bio Science Group Ltd. pay dividends?
Uni-Bio Science Group Ltd. pays a Notavailable dividend of HK$0.003 which represents an annual dividend yield of 2.29%. See more information on Uni-Bio Science Group Ltd. dividends here
What is Uni-Bio Science Group Ltd.’s EPS estimate?
Uni-Bio Science Group Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Uni-Bio Science Group Ltd. have?
Uni-Bio Science Group Ltd. has 5,971,228,000 shares outstanding.
What happened to Uni-Bio Science Group Ltd.’s price movement after its last earnings report?
Uni-Bio Science Group Ltd. reported an EPS of HK$0.013 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Uni-Bio Science Group Ltd.?
Currently, no hedge funds are holding shares in HK:0690
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Uni-Bio Science Group Ltd. Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
83.87%
12-Months-Change
Fundamentals
Return on Equity
26.27%
Trailing 12-Months
Asset Growth
14.16%
Trailing 12-Months
Company Description
Uni-Bio Science Group Ltd.
Uni-Bio Science Group Ltd. (0690) is a biotechnology company based in Hong Kong, primarily engaged in the research, development, manufacturing, and commercialization of high-quality biopharmaceutical products. The company focuses on the fields of oncology, autoimmune diseases, and other therapeutic areas, providing innovative solutions through its proprietary technologies and product pipelines. Uni-Bio Science is committed to enhancing patient care and improving health outcomes by delivering cutting-edge biopharmaceuticals and engaging in collaborations that expand its market reach.
Technical Analysis
Kintor Pharmaceutical Ltd
―
3D Medicines, Inc.
―
JW (Cayman) Therapeutics Co. Ltd.
―
Sirnaomics Ltd.
―
Transcenta Holding Limited
―
Options Prices
Currently, No data available
---